Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1426 AL 1440

High intensity aerobic exercise improves bimanual coordination of grasping forces in Parkinson's disease

Jansen AE, Koop MM, Rosenfeldt AB, Alberts JL.

Parkinsonism Relat Disord. 2021 Jun;87:13-19. doi: 10.1016/j.parkreldis.2021.04.005. Epub 2021 Apr 20.

Gastrointestinal surgery improved the absorption of levodopa in Parkinson's disease

Miyaue N, Yabe H, Nagai M.

Parkinsonism Relat Disord. 2021 Jun;87:20-21. doi: 10.1016/j.parkreldis.2021.04.009. Epub 2021 Apr 24.

Effect of aerobic exercise on functional capacity and quality of life in individuals with Parkinson's disease: A systematic review of randomized controlled trials

de Oliveira MPB, Lobato DFM, Smaili SM, Carvalho C, Borges JBC.

Arch Gerontol Geriatr. 2021 Jul-Aug;95:104422. doi: 10.1016/j.archger.2021.104422. Epub 2021 Apr 20.

Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients

Isaacson SH, Ballard CG, Kreitzman DL, Coate B, Norton JC, Fernandez HH, Ilic TV, Azulay JP, Ferreira JJ, Abler V, Stankovic S; 015 Study Group.

Parkinsonism Relat Disord. 2021 Jun;87:25-31. doi: 10.1016/j.parkreldis.2021.04.012. Epub 2021 Apr 28.

Dementia and Parkinson-like syndrome with basal ganglia lesion in neuromyelitis optica spectrum disorders

Hiraga A, Mori M, Kuwabara S.

Neurocase. 2021 Apr;27(2):223-226. doi: 10.1080/13554794.2021.1921222. Epub 2021 May 2.

Hormonal replacement therapy in women with a history of internal genital organ malignancy

Brzozowska M, Lewinski A.

Prz Menopauzalny. 2021 Apr;20(1):34-39. doi: 10.5114/pm.2021.104572. Epub 2021 Mar 18.

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC.

Front Pharmacol. 2021 Apr 15;12:648636. doi: 10.3389/fphar.2021.648636. eCollection 2021.

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease

Pérez-Lloret S, Cardinali DP.

Front Pharmacol. 2021 Apr 15;12:650597. doi: 10.3389/fphar.2021.650597. eCollection 2021.

The Promise of the Zebrafish Model for Parkinson's Disease: Today's Science and Tomorrow's Treatment

Razali K, Othman N, Mohd Nasir MH, Doolaanea AA, Kumar J, Ibrahim WN, Mohamed Ibrahim N, Mohamed WMY.

Front Genet. 2021 Apr 15;12:655550. doi: 10.3389/fgene.2021.655550. eCollection 2021.

Hemi-parkinsonism and return of essential tremors after MRgFUS thalamotomy: Case report and review of procedural complications affecting ventral thalamic nuclei

Varma-Doyle AV, Villemarette-Pittman NR, Copeland BJ.

eNeurologicalSci. 2021 Apr 13;23:100339. doi: 10.1016/j.ensci.2021.100339. eCollection 2021 Jun.

Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases

Koss DJ, Campesan S, Giorgini F, Outeiro TF.

Mov Disord. 2021 Aug;36(8):1744-1758. doi: 10.1002/mds.28605. Epub 2021 May 3.

Shared decision-making in neurosurgery: a scoping review

Corell A, Guo A, Vecchio TG, Ozanne A, Jakola AS.

Acta Neurochir (Wien). 2021 Sep;163(9):2371-2382. doi: 10.1007/s00701-021-04867-3. Epub 2021 May 3.

What the Tech? The Management of Neurological Dysfunction Through the Use of Digital Technology

Carswell C, Rea PM.

Adv Exp Med Biol. 2021;1317:131-145. doi: 10.1007/978-3-030-61125-5_7.

Sensory Attenuation in Sport and Rehabilitation: Perspective from Research in Parkinson's Disease

Kearney J, Brittain JS.

Brain Sci. 2021 Apr 30;11(5):580. doi: 10.3390/brainsci11050580.

Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy

Subedi L, Gaire BP, Parveen A, Kim SY.

Int J Mol Sci. 2021 Apr 30;22(9):4771. doi: 10.3390/ijms22094771.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias